KLK3 and prostate carcinoma: In order to further characterize the effect of treatment modality among higher risk prostate cancer patients, three additional PSM analyses (1–1 nearest neighbor matching without replacement) were carried out within patients having a pretreatment PSA > 10 or GS > 7 or GS = 7.